Six-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses

International Journal of Gynecological Cancer

Volumn 23, Issue 4, 2013, Pages 716-723

  Wang, Shao Ming ^a   Colombara, Danny ^a,b   Shi, Ju Fang ^c   Zhao, Fang Hui ^a   Li, Jing ^a   Chen, Feng ^a   Chen, Wen ^a   Li, Shu Min ^c   Zhang, Xun ^c   Pan, Qin Jing ^c   Belinson, Jerome L ^d   Smith, Jennifer S ^e   Qiao, You Lin ^a  

^a CANCER HOSPITAL   (China)

^b UNIVERSITY OF WASHINGTON   (United States)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d LERNER RESEARCH INSTITUTE   (United States)

^e IL   (United States)

Author keywords

Cervical intraepithelial neoplasia; Hazard ratios; Human papillomavirus viral load; Progression; Regression

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CHINA; COLPOSCOPY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS LOAD; WART VIRUS;

ADULT; BIOLOGICAL MARKERS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DISEASE PROGRESSION; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; REMISSION, SPONTANEOUS; SOCIOECONOMIC FACTORS; TRIAGE; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 84879993378     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318286a95d     Document Type: Article

References (25)

1. Zhao F-H, Lin MJ, Chen F, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol. 2010;11:1160-1171.
2. Arbyn M, de Sanjosé S, Saraiya M, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer. 2012;131:1969-1982.
3. WHO. Comprehensive Cervical Cancer Control: A Guide to Essential Practice. Geneva, Switzerland: World Health Organization; 2006.
4. Ovestad IT, Gudlaugsson E, Skaland I, et al. The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2-3. J Clin Pathol. 2011;64: 303-307.
5. Moscicki A-B, Ma Y, Wibbelsman C, et al. Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol. 2010;116: 1373-1380.
6. Zhao F-H, Hu S-Y, Wang S-M, et al. Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia [In Chinese]. Zhonghua yu fang yi xue za zhi. 2009;43:565-570.
7. Li L, Lu F, Zhang S, et al. Cancer mortality trends in the People's Republic of China: 1973-1992. Chinese J Oncol. 1997;19:3-9.
8. Belinson J, Qiao YL, Pretorius R, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol. 2001;83:439-444.
9. Shi J-F, Belinson JL, Zhao F-H, et al. Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China. Am J Epidemiol. 2009;170: 708-716.
10. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
11. Gravitt PE, Kovacic MB, Herrero R, et al. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int J Cancer. 2007;121:2787-2793.
12. Constandinou-Williams C, Collins SI, Roberts S, et al. Is human papillomavirus viral load a clinically useful predictive marker? A longitudinal study. Cancer Epidemiol Biomarkers Prev. 2010;19:832-837.
13. Xi LF, Koutsky LA, Castle PE, et al. Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. J Natl Cancer Inst. 2009;101:153-161.
14. Hesselink AT, Berkhof J, Heideman DA, et al. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer. Int J cancer. 2009;124:381-386.
15. Wu Y, Chen Y, Li L, et al. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol. 2006;35:264-269.
16. Dalstein V, Riethmuller D, Prétet J-L, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer. 2003;106:396-403.
17. Rebolj M, Bonde J, Njor SH, et al. Human papillomavirus testing in primary cervical screening and the cut-off level for Hybrid Capture 2 tests: systematic review. BMJ. 2011;342:d2757.
18. Nasiell K, Nasiell M, Vaćlavinková V. Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol. 1983;61:609-614.
19. Syrjänen K, Kataja V, Yliskoski M, et al. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol. 1992;79:675-682.
20. Trimble CL, Piantadosi S, Gravitt P, et al. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clin Cancer Res. 2005;11:4717-4723.
21. Carreon JD, Sherman ME, Guillén D, et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol. 2007;26:441-446.
22. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11:249-257.
23. Sun C, Reimers LL, Burk RD. Gynecologic oncology methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol. 2011;121:59-63.
24. Pino M, Landolfi S, Torne A, et al. p16 INK4a immunostaining identifies occult CIN lesions in HPV-positive women. Int J Gynecol Pathol. 2008;28:90-97.
25. Darragh TM, Colgan TJ, Cox JT, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16:205-242.